# fosaprepitant

NDC: 71839-104
Generic name: fosaprepitant
Labeler / Manufacturer: BE Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20191015

FDA application: ANDA212309

## Active ingredients

- FOSAPREPITANT DIMEGLUMINE: 150 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71839-104"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71839-104
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21b08b87-70e3-4233-9531-dd6d84eab5d0